Eran Segal, PhD, previews his presentation “Efficacy of Personalized Nutrition Based on Gut Microbiome and Clinical Data in Prediabetes,” which begins at 11:40 a.m. CT Saturday, June 13.

John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial,” which begins at 6 p.m. CT Friday, June 12.

Linda A. Barbour, MD, MSPH, FACP, Professor of Endocrinology and Maternal-Fetal Medicine, University of Colorado Anschutz Medical Campus, previews her presentation “Oral Agents for Gestational Diabetes Mellitus—Are We Stuck Using Insulin?” which begins at 1:15 p.m. CT Friday, June 12.

Josep Vehí, PhD, previews his presentation “AI for Risk Assessment and Blood Glucose Control,” which begins at 2:15 p.m. CT Monday, June 15.

Joan K. Bardsley, MBA, RN, CDCES, FAADE, previews her presentation “Call to Action—Recommendations and the Four Critical Times,” which begins at 12:40 p.m. Sunday, June 14, and is part of Professional Interest Group Discussion on Diabetes Self-Management Education and Support (DSMES)—Focus on 2020 DSMES Consensus Report.

During the Scientific Sessions, Scott A. Summers, PhD, reviewed the strong association of serum ceramides with insulin resistance and major adverse cardiac events. He also discussed new therapeutic approaches to lower ceramides and combat diabetes and its comorbidities.

Erin Phillips, MPH, RDN, CDCES, previews her presentation “Definition and Benefits of a Weight-Neutral Approach,” which begins at 12:45 p.m. CT Friday, June 12.

Emma E. Hamilton-Williams, PhD, describes results from the TOGeTHER Trial of type 1 diabetes patients, who were treated with a specially modified dietary fiber designed to deliver short-chain fatty acids into the large intestine. Her presentation details the impact of the supplement on the gut bacteria and diabetes management of the participants, revealing a promising…

John JV McMurray, OBE, BSc (Hons), MB, ChB (Hons), MD, Professor of Medical Cardiology, University of Glasgow, previews his presentation “What Do We Know about the Effects of Antihyperglycemic Medication on Heart Failure?” which begins at 2:35 p.m. CT Friday, June 12.

Jessica L. Turton, APD, BAppSc (Ex&SpSc), MNutriDiet, previews her presentation “Low-Carbohydrate Diets and Nutritional Ketosis,” which begins at 2:30 p.m. CT Friday, June 12.